G. Bartholini

6.2k total citations
133 papers, 5.0k citations indexed

About

G. Bartholini is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, G. Bartholini has authored 133 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cellular and Molecular Neuroscience, 49 papers in Molecular Biology and 17 papers in Physiology. Recurrent topics in G. Bartholini's work include Neuroscience and Neuropharmacology Research (55 papers), Neurotransmitter Receptor Influence on Behavior (33 papers) and Receptor Mechanisms and Signaling (21 papers). G. Bartholini is often cited by papers focused on Neuroscience and Neuropharmacology Research (55 papers), Neurotransmitter Receptor Influence on Behavior (33 papers) and Receptor Mechanisms and Signaling (21 papers). G. Bartholini collaborates with scholars based in Switzerland, France and United States. G. Bartholini's co-authors include A. Pletscher, Kenneth G. Lloyd, H. H. Keller, B. Scatton, R Tissot, Heinz Stadler, W.P. Burkard, B. Živković, P. Worms and Isami Kuruma and has published in prestigious journals such as Nature, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

G. Bartholini

130 papers receiving 4.5k citations

Peers

Countries citing papers authored by G. Bartholini

Since Specialization

Citations

This map shows the geographic impact of G. Bartholini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Bartholini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Bartholini more than expected).

Fields of papers citing papers by G. Bartholini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Bartholini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Bartholini. The network helps show where G. Bartholini may publish in the future.

Co-authorship network of co-authors of G. Bartholini

This figure shows the co-authorship network connecting the top 25 collaborators of G. Bartholini. A scholar is included among the top collaborators of G. Bartholini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Bartholini. G. Bartholini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Difluoromethyl ornithine protects against the neurotoxic effects of intrastriatally administered N-methyl-D-aspartate in vivo 1991 ·European Journal of Pharmacology ·Anna Porcella, Dominique Fage, C. Voltz, Christopher Carter, B. Scatton, G. Bartholini	33
2	The psychopharmacology of GABA synapses: update 1989 1990 ·PubMed ·Kenneth G. Lloyd, Philippe Pichat, B. Scatton, B. Živković, P. L. Morselli, G. Bartholini	8
3	Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra 1987 ·Brain Research ·André Oblin, Branimir Ẑivković, G. Bartholini	16
4	Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·B. Scatton, Kenneth G. Lloyd, B. Živković, T Dennis, Y. Claustre, J. Dedek, S. Arbilla, S Z Langer, G. Bartholini	22
5	GABA and mood disorders : experimental and clinical research 1986 ·Raven Press eBooks ·G. Bartholini, (unknown), P. L. Morselli	22
6	Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. 1986 ·Journal of Pharmacology and Experimental Therapeutics ·H. Depoortere, B. Živković, (unknown), D. J. Sanger, Ghislaine Perrault, Salomón Z. Langer, G. Bartholini	247
7	Epilepsy and GABA receptor agonists : basic and therapeutic research 1985 ·Raven Press eBooks ·G. Bartholini	23
8	The GABA hypothesis of depression and antidepressant drug action. 1985 ·PubMed ·G. Bartholini, Lloyd Kg, B. Scatton, B. Živković, Morselli Pl	20
9	GABAERGIC MECHANISMS AND ANTIDEPRESSANT THERAPY 1984 ·Clinical Neuropharmacology ·G. Bartholini, B. Scatton, B. Živković, H. Depoortere, Kenneth G. Lloyd	1
10	gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. 1982 ·Journal of Pharmacology and Experimental Therapeutics ·B. Scatton, B. Živković, J. Dedek, Kenneth G. Lloyd, J Constantinidis, R Tissot, G. Bartholini	77
11	gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas. 1982 ·Journal of Pharmacology and Experimental Therapeutics ·B. Scatton, G. Bartholini	62
12	On the therapeutic action of SL 76 002, a new GABA-mimetic agent: Preliminary observations in neuropsychiatric disorders 1980 ·Brain Research Bulletin ·P. L. Morselli, Laura Bossi, J. F. Henry, E. Zarifian, G. Bartholini	47
13	[Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry]. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·G. Bartholini	3
14	Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·G. Bartholini	12
15	ABSENCE OF DEGENERATION OF ADRENERGIC NEURONS AFTER PROLONGED TREATMENT WITH DEBRISOQUIN 1974 ·Journal of Pharmacology and Experimental Therapeutics ·G. Haeusler, H.P. Lorez, G. Bartholini, R. Kettler, J. P. Tranzer	7
16	THE METABOLIC PATHWAYS OF l-3-O-METHYLDOPA 1972 ·Journal of Pharmacology and Experimental Therapeutics ·G. Bartholini, Isami Kuruma, A. Pletscher	24
17	Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase 1971 ·Biochemical Pharmacology ·G. Bartholini, J Constantinidis, R Tissot, A. Pletscher	61
18	Brain capillaries as a source of homovanillic acid in cerebrospinal fluid 1971 ·Brain Research ·G. Bartholini, R Tissot, A. Pletscher	20
19	Temperature dependence of the passive in- and outflow of 5-hydroxytryptamine in blood platelets 1966 ·Biochemical Pharmacology ·A. Pletscher, M. Da Prada, G. Bartholini	8
20	Formation of 5-hydroxytryptophol by blood platelets after thrombin and reserpine 1965 ·Cellular and Molecular Life Sciences ·M. Da Prada, G. Bartholini, A. Pletscher	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact